Market Overview

Caladrius Biosciences (NASDAQ: CLBS)

2.47 +0.01 (0.41%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/14/19WBB SecuritiesInitiates Coverage OnSpeculative Buy6.8
3/23/18Chardan CapitalMaintainsBuy7.0
3/07/18H.C. WainwrightMaintainsBuy12.0
8/23/16Chardan CapitalInitiates Coverage onBuy6.5
4/29/16H.C. WainwrightUpgradesBuy
1/08/16BenchmarkMaintainsHold1.0
1/08/16H.C. WainwrightDowngradesNeutral
1/07/16Maxim GroupDowngradesHold
8/07/15BenchmarkDowngrades

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter